Table 1.
Most common symptoms in the post-acute phase of COVID-19.
| Halpin et al. | Carfi et al. | Xiong et al. | Göertz et al. | Moreno-Pérez et al. | Huang et al. | |
|---|---|---|---|---|---|---|
| Follow-up | 1−2 months after hospital discharge | 2 months from symptom onset | 3 months | 3 months | 2−3 months from symptom onset | 6 months from symptom onset |
| Patients | 100 | 143 | 538 | 2.159 | 277 | 1.733 |
| Age (median [IQR]) | 70.5 in ward 58.5 in ICU | 56.5 (14.6)a | 52.0 (41.0−62.0) | 47.0 (39.0−54.0) | 56 (42−67.5) | 57 (47−65) |
| Asthenia (%) | 64 | 53.1 | 28.3 | 87 | 34.8 | 63 |
| Arthralgia (%) | – | 27.3 | 7.6 | 22 | 19.6 | 9 |
| Headache (%) | – | 10 | – | 38 | 17.8 | 2 |
| Dyspnoea (%) | 40 | 43.4 | 21.4 | 71 | 34.4 | 23 |
| Cough (%) | – | 15 | 7.1 | 29 | 21.3 | – |
| Anosmia/Ageusia (%) | – | 15 | – | 12 | 21.4 | 7−11 |
| Sleep disorders (%) | – | – | 17.7 | – | – | 26 |
| Anxiety Depression (%) | – | – | 5 | – | – | 23 |
| Post-traumatic stress disorder (%) | 31 | – | – | – | – | – |
| Palpitations (%) | – | – | 11.2 | 32 | – | 9 |
| Chest pain (%) | – | 21.7 | 12.3 | 44 | 5 | |
| Decreased quality of life (EQ5D-SF36) | Yes | 44.1% | – | – | Yes | Yes |
IQR: interquartile range; ICU: intensive care unit.
a
Mean (SD).